CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for SeQuent Scientific Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

SeQuent Scientific Ltd
301/A, 3rd Floor,
Dosti Pinnacle,, Plot No.E7,Road No. 22
Phone: +91 2241114777p:+91 2241114777 MUMBAI, 400604  India Ticker: SEQUENTSEQUENT
Business Summary
SeQuent Scientific Limited is an India-based animal health company. The Company provides a wide range of animal health products, including finished dose formulations, active pharmaceutical ingredients (APIs), as well as analytical services. The Company operates through the pharmaceuticals segment. The Company is focused on various therapies, such as targeted are anthelmintics (endo and ecto parasiticides), anti-protozoals, nutraceuticals, nonsteroidal anti-inflammatory drugs (NSAIDs), anti-infectives and dermatology. It is specialized in analytical and bio analytical services to support the API, pharmaceutical, personal care and nutraceutical companies. It provides analytical solutions, including method validation, stability, microbiology for APIs and finished products in a variety of dosage forms as per pharmacopoeia monographs, customer developed methods or in-house method development. The Company’s subsidiaries include Alivira Animal Health Limited and SeQuent Research Limited.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/20243/31/2024Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Non-Executive Chairman of the Board Kamal K.Sharma 75 1/1/2023 8/25/2020
Chief Executive Officer, Managing Director, Executive Director RajaramNarayanan 55 4/11/2022 4/11/2022
Chief Financial Officer SauravBhala 11/6/2023 11/6/2023
12 additional Officers and Directors records available in full report.

Business Names
Business Name
Alivira Animal Health
Nourrie Saude e Nutricao Animal Ltd
P I Drugs & Pharmaceuticals Ltd
SEQUENT
Sequent Scientific Limited

General Information
Number of Employees: 1,195 (As of 3/31/2024)
Outstanding Shares: 249,349,745 (As of 10/29/2024)
Shareholders: 169,737
Stock Exchange: NSE
Fax Number: +91 2241114754


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024